1-2 of 2
Salih Aksu, MDPROF.
Close
Sort by
Journal Articles

Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

Fatma Keklik Karadag, MD, Mustafa Nuri Yenerel, MD, Yılmaz Mehmet, MD, Hava uskudar Teke, MD, Vildan Ozkocaman, MD, Tulin Tuglular, MD, Fuat Erdem, MD, Ali Unal, MD, Orhan Ayyildiz, MD, Gulsum Ozet, MD, Melda Ozkan, MD, Emin Kaya, MD, Mesut Ayer, MD, Ozan Salim, MD, Birol Güvenç, MD, Hakan Ozdogu, MD, Özgür Mehtap, MD, Mehmet Sönmez, MD, Nil Güler, MD, Sibel Kabukcu Hacioglu, MD, Ismet Aydogdu, MD, Ozlen Bektas, MD, Selami Kocak Toprak, MD, Lale Kaynar, MD, Munci Yagci, MD, Salih Aksu, MDPROF., Anil Tombak, MD, Volkan Karakus, MD, Irfan Yavasoglu, MD, Birgül Öneç, MD, Mehmet Ali Özcan, MD, Levent Ündar, MD, Rıdvan Ali, MD, Celalettin Ustun, MD, Osman Ilhan, MD, Guray Saydam, MD, Fahri Sahin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4805.
https://doi.org/10.1182/blood-2019-128743
Published: 2019
Journal Articles

Long-Term Results of Non- Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

Elifcan Aladag, MD, Haluk Demiroglu, MDPROF., Rafiye Ciftciler, MD, Yahya Buyukasik, MDPROF., Nilgun Sayinalp, MDPROF., Salih Aksu, MDPROF., Ibrahim Celalettin Haznedaroglu, MDPROF., Osman Ozcebe, MDPROF., Nelson J. Chao, MD, Hakan Goker, MDPROF.
Journal: Blood
Blood (2018) 132 (Supplement 1): 5700.
https://doi.org/10.1182/blood-2018-99-110131
Published: 2018